Literature DB >> 2957263

Immune regulation and the eye: a dangerous compromise.

J W Streilein.   

Abstract

The thesis is advanced that immune responses to intraocular antigens are unique and highly specialized. Anterior chamber-associated immune deviation (ACAID) is the term used to identify this specialized response, which consists of selectively impaired immunity of the delayed hypersensitivity (DH) type coexistent with intact humoral immunity and priming of cytotoxic T cell activity. Induction of T cell suppression, which is partly responsible for ACAID, interferes with expression of DH within the eye as well as systemically. It is proposed that the ability of the eye to make a compromise with the immune system and thereby arrange for the selective suppression of delayed hypersensitivity results from the need to avoid intraocular inflammatory reactions that are intense and productive of nonspecific "innocent bystander" injury. When reactions of this type occur within the eye, the visual axis is disrupted, and vision is destroyed. However, avoidance of DH may have deleterious consequences both for the eye and for the host. The impact of ACAID is discussed with regard to the distinctive patterns of ocular disease produced experimentally in mice by melanoma cells and by herpes simplex virus type 1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957263

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

Review 1.  Immunologic privilege of the eye.

Authors:  J W Streilein
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Ocular molecules and cells that regulate immune responses in situ.

Authors:  J W Streilein; S Cousins; J S Williamson
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

3.  Anterior chamber-associated immune deviation-inducing cells activate T cells, and rescue them from antigen-induced apoptosis.

Authors:  M Takeuchi; P Alard; D Verbik; B Ksander; J W Streilein
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 4.  [Viral and nonviral gene therapy for treatment of retinal diseases].

Authors:  J Neidhardt; K Wycisk; B Klöckener-Gruissem
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

5.  The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation.

Authors:  Koh-Hei Sonoda; Taiji Sakamoto; Hong Qiao; Toshio Hisatomi; Toru Oshima; Chikako Tsutsumi-Miyahara; Mark Exley; Steven P Balk; Masaru Taniguchi; Tatsuro Ishibashi
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

Review 6.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

7.  Local "on-demand" generation and function of antigen-specific Foxp3+ regulatory T cells.

Authors:  Scott W McPherson; Neal D Heuss; Dale S Gregerson
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

8.  Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.

Authors:  Xingya Li; Yafei Wang; David Urso; James O'Rourke; Robert E Cone
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

9.  Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.

Authors:  I Kurimoto; S F Grammer; T Shimizu; T Nakamura; J W Streilein
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

10.  Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.

Authors:  Liqiong Jiang; Peizeng Yang; Hao He; Bing Li; Xiaomin Lin; Shengping Hou; Hongyan Zhou; Xiangkun Huang; Kijlstra Aize
Journal:  Mol Vis       Date:  2007-06-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.